Association between serum iron levels and the risk of cervical cancer in Chinese: a meta-analysis

Abstract

Objectives

To evaluate the association between serum iron levels and cervical cancer risk in Chinese populations.

Methods

A literature search was conducted using the PubMed, WanFang, and SinoMed databases up to April 30, 2019. Pooled standard mean differences (SMD) and 95% confidence intervals (CI) were analyzed using R software with a random-effects model.

Results

Data from nine studies comprising 454 cervical cancer patients and 880 controls were used in the analysis. Our results demonstrated that serum iron levels in cervical cancer patients were significantly lower than those in controls in Chinese populations (summary SMD = −1.24, 95%CI = −1.37 to −1.10; I² = 93.4%). No publications bias was detected. Sensitivity analysis indicated that no single study had a significant effect on the overall SMD.

Conclusions

Our findings show that serum iron levels are lower in patients with cervical cancer than in control individuals. However, further high-quality studies are necessary to clarify the role of serum iron levels in cervical cancer risk.

Keywords

Serum iron levels cervical cancer meta-analysis Chinese

Introduction

Cervical cancer is among the most common malignancies in women and a leading cause of death among women worldwide.^1–3 According to a previous study, there were 527,600 new cases of cervical cancer in women worldwide in 2012, with 265,700 deaths.⁴ In 2015 there were approximately 98,900 new cases of cervical cancer in China,⁵ and the prevention of this disease has subsequently become a public health priority. Recently, Zhang et al.⁶ performed a meta-analysis to examine the association between serum copper levels and cervical cancer risk. The results from that study indicated that serum copper levels were higher in cervical cancer patients than in control individuals. Furthermore, Xie et al.⁷ conducted a meta-analysis of the association between serum zinc levels and cervical cancer risk, and found that serum zinc levels were significantly lower in cervical cancer patients compared with controls. Zinc, copper, and iron are all trace elements, and to our knowledge, no meta-analysis to date has evaluated the association between serum iron levels and cervical cancer risk. We therefore performed the current meta-analysis to clarify whether a relationship exists between serum iron levels and risk of cervical cancer. Our results may support preventative efforts in the treatment of this disease.

Materials and methods

This study was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement.⁸

Literature search

We considered all studies related to serum iron levels and cervical cancer risk published prior to April 30, 2019 for inclusion in our study. The literature search was conducted by two independent authors (SC and LYS) using the PubMed, WanFang, and SinoMed databases and the following combination terms: (‘iron concentration’ OR ‘iron level’ OR ‘iron’ OR ‘Fe’ OR ‘trace element’) AND ‘cervical’ AND (‘cancer’ OR ‘tumor’ OR ‘carcinoma’). Additional studies were identified by manually searching the references cited in eligible articles. Disagreements between the two authors were resolved by a third author (SJL). Ethics review committee approval was not required for this meta-analysis.

Inclusion and exclusion criteria

Studies that met all of the following criteria were included: (1) observational study or randomized controlled trial (RCT) to investigate the association between serum iron levels and cervical cancer risk; (2) values, means, and standard deviations (SDs) of serum iron levels available for cases and controls; and (3) studies conducted in humans. Studies were excluded if they met the following criteria: (1) reviews, case reports, comments, conference abstracts, letters, or laboratory studies; (2) insufficient data available to estimate the association between serum iron levels and cervical cancer risk.

Data extraction

Detailed information on the data extracted by the two independent authors (SC and LYS) are provided in Table 1.

Table 1.

Characteristics of included studies.

Study	Year	Country	Case age (range)	Study type	Cervical cancer cases		Controls
Study	Year	Country	Case age (range)	Study type	n	Iron: Mean ± SD(μmol/L)	n	Iron: Mean ± SD(μmol/L)
Cunzhi et al.	2003	China	30–65	Case-control	40	20 ± 10	50	23 ± 7
Fu et al.	2009	China	31–70	Case-control	74	15.73 ± 2.18	180	22.58 ± 6.49
He et al.	2012	China	27–69	Case-control	60	12.11 ± 2.63	30	19.19 ± 3.42
Ji et al.	2014	China	30–65	Case-control	40	21 ± 11	100	71 ± 21
Jie et al.	1991	China	32–54	Case-control	36	14.92 ± 0.29	36	15.13 ± 0.42
Wang et al.	2010	China	25–60	Case-control	41	12.45 ± 2.62	260	19.45 ± 5.34
Yu et al.	2016	China	36–65	Case-control	70	5.8 ± 1.4	150	6.62 ± 1.7
Zhang et al.	2015	China	32–70	Case-control	58	51.8 ± 1.2	50	58.7 ± 4.2
Zhou et al.	2005	China	30–65	Case-control	35	14.73 ± 1.87	24	23.32 ± 7.46

SD: standard deviation.

Statistical analysis

The overall and subgroup associations between serum iron levels and cervical cancer risk were assessed using standard mean differences (SMD) and the corresponding 95% confidence intervals (CI) with a random-effects model.⁹ Heterogeneity among studies was detected using an I² statistic, according to the Q-test.¹⁰ I² > 50% indicated significant between-study heterogeneity.¹¹ Sensitivity analysis was performed to determine whether a single study could affect the overall result. Egger’s test¹² and Begg’s test¹³ were used to detect publication bias. Our meta-analysis was performed using R (www.r-project.org), and values of p < 0.05 were considered significant.

Results

Research characteristics

In total, 237 published manuscripts (106 from PubMed, 61 from WanFang, and 70 from SinoMed) that evaluated the association between serum iron levels and cervical cancer and met the inclusion and exclusion criteria were identified. The flowchart in Figure 1 shows the reasons for inclusion or exclusion. The final analysis was conducted using data from 9 studies^14–22 comprising 454 cervical cancer patients and 880 controls. All eligible articles had been published between 1991 and 2016. The included studies were of case-control design and were conducted in Chinese patient populations. The characteristics of each study are presented in Table 1.

Figure 1.

Flow diagram of the literature search.

Figure 2.

Forest plot of standard mean difference (SMD) with corresponding 95% confidence interval (CI) of studies on serum iron levels and cervical cancer risk.

Meta-analysis

Our results demonstrated that serum iron levels in cervical cancer patients were significantly lower than those in controls in Chinese populations (summary SMD =−1.24, 95%CI = −1.37 to −1.10, Z test =18.23, P < 0.001; I² = 93.4%, P_{for heterogeneity} < 0.001) (Figure 2). Sensitivity analysis showed that no individual study had a significant impact on the overall results, indicating the reliability and stability of the meta-analysis. Publication bias was not detected using either Begg's test or Egger's test.

Discussion

We conducted the present meta-analysis to explore the relationship between serum iron levels and risk of cervical cancer. Our findings, based on nine studies involving 454 patients with cervical cancer and 880 control individuals, indicate that serum iron levels in cervical cancer are significantly lower than those in controls in Chinese populations.

In the overall analysis, the P value for the heterogeneity test was < 0.001, indicating that significant between-study heterogeneity existed in the pooled result. Sensitivity analysis was carried out to explore whether a single study could affect the overall result. However, none of the individual studies were found to have an influence on the overall result. Publication bias was also assessed by Egger’s test and Begg’s test, and the results showed that no publication bias existed in our study. Taken together, the results of these analyses indicate that our meta-analysis was reliable and robust, despite the high between-study heterogeneity identified.

We searched the PubMed, WanFang, and SinoMed databases to identify eligible studies that assessed the association of serum iron levels with cervical cancer risk. Of note, all studies that met our inclusion and exclusion criteria were conducted in China. However, from another perspective, all included studies were in Chinese populations with a relatively consistent genetic and lifestyle background, thus excluding any effect related to geographic location.

Trace elements are essential for the normal functioning of various metabolic processes in the body. Recent studies have shown that trace elements play an important role in the development and progression of malignant tumors.²³ Iron participates in the synthesis of hemoglobin, myoglobin, cytochrome oxidase, and peroxidase, and iron-containing enzymes proliferate rapidly in hepatocytes to increase iron requirements.²⁴ Furthermore, vaginal bleeding in cervical cancer may lead to a loss of iron and subsequent reduction in serum iron levels in this patient population.

Our study had some limitations. First, only nine studies were included in our meta-analysis. Only published papers were included, meaning that relevant unpublished studies or meeting abstracts may have been omitted. Second, between-study heterogeneity was present in the overall analysis. Hence, further studies are required to explore this high level of heterogeneity. Finally, all included studies were conducted in China, meaning that our results are applicable primarily to Chinese populations. Further studies are thus needed to confirm the association between serum iron levels and cervical cancer risk in other populations.

Conclusions

The results of this study show that serum iron levels are lower in cervical cancer patients compared with controls, indicating that higher serum iron levels may have a protective effect in cervical cancer. However, given the limitations of our meta-analysis, further high-quality studies are needed to clarify the role of serum iron levels in cervical cancer risk.

Footnotes

Acknowledgements

None.

Declaration of conflicting interests

The authors declare that there is no conflict of interest.

Funding

This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.

ORCID iD

Lan Wang

References

Shrestha

Neupane

Vedsted

, et al. Cervical cancer prevalence, incidence and mortality in low and middle income countries: a systematic review. Asian Pac J Cancer Prev 2018; 19: 319–324.

Bahadoor-Yetman

Riley

Gibbons

, et al. Prevalence of cervical cancer and associated mortality in Grenada, 2000-2010. Rev Panam Salud Publica 2016; 39: 194–199.

Wang

Zeng

Huang

, et al. Prevalence and genotype distribution of human papillomavirus in invasive cervical cancer, cervical intraepithelial neoplasia, and asymptomatic women in Southeast China. Biomed Res Int 2018; 2018: 2897937.

Torre

Bray

Siegel

, et al. Global cancer statistics, 2012. CA Cancer J Clin 2015; 65: 87–108.

Chen

Zheng

Baade

, et al. Cancer statistics in China, 2015. CA Cancer J Clin 2016; 66: 115–132.

Zhang

Shi

Zhao

Association between serum copper levels and cervical cancer risk: a meta-analysis.

Biosci Rep 2018; 38: pii: BSR20180161.

Xie

Wang

Zhao

, et al. Higher serum zinc levels may reduce the risk of cervical cancer in Asian women: a meta-analysis. J Int Med Res 2018; 46: 4898–4906.

Moher

Liberati

Tetzlaff

, et al. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. PLoS Med 2009; 6: e1000097.

DerSimonian

Laird

Meta-analysis in clinical trials.

Control Clin Trials 1986; 7: 177–188.

10.

Higgins

Thompson

Deeks

, et al. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557–560.

11.

Higgins

Thompson

SG.

Controlling the risk of spurious findings from meta-regression.

Stat Med 2004; 23: 1663–1682.

12.

Egger

Davey Smith

Schneider

, et al. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629–634.

13.

Begg

Mazumdar

Operating characteristics of a rank correlation test for publication bias.

Biometrics 1994; 50: 1088–1101.

14.

Cunzhi

Jiexian

Xianwen

, et al. Serum and tissue levels of six trace elements and copper/zinc ratio in patients with cervical cancer and uterine myoma. Biol Trace Elem Res 2003; 94: 113–122.

15.

Zhou

Chao

HJ.

Detection of blood trace elements in gynecologic oncology patients and its significance.

Shandong Med 2009; 49: 87–88.

16.

Cai

Cao

Discussion on the changes of serum trace elements levels in patients with cervical cancer. Chin Maternal and Child Health Care 2012: 4681–4682.

17.

Liu

, et al. Comparison of serum and tissue levels of trace elements in different models of cervical cancer. Biol Trace Elem Res 2014; 159: 346–350.

18.

Jie

Chen

, et al. [Analysis of serum trace elements copper, zinc and iron in 36 patients with cervical cancer]. J of Lanzhou College 1991; 17: 168–170.

19.

Wang

Zhang

QZ.

Analysis of serum trace elements in patients with gynecological malignancies. Med J West China 2010; 22: 2046–2047.

20.

Wang

LH.

The factors associated with serum trace element levels and the incidence of cervical diseases/cancer in Qinghai females. Chin J Gerontol 2016; 36: 3774–3775.

21.

Zhang

, et al. The relationship between serum trace element levels and cervical diseases in Uighur females of southern Xinjiang. Acta Universitatis Medicinalis Nanjing 2015; 35: 557–560.

22.

Zhou

RZ.

[The changes of trace elements in the serum of cervical cancer patients before and after operation].

Sichuan Cancer Prev 2005; 18: 21–23.

23.

Han

Yuan

, et al. Comparison of hypoglycemic activity of trace elements absorbed in fermented mushroom of Coprinus comatus. Biol Trace Elem Res 2009; 131: 177–185.

24.

Schwartz

MK.

Role of trace elements in cancer.

Cancer Res 1975; 35: 3481–3487.